Literature DB >> 3299376

Heterologous transmembrane signaling by a human insulin receptor-v-ros hybrid in Chinese hamster ovary cells.

L Ellis, D O Morgan, S M Jong, L H Wang, R A Roth, W J Rutter.   

Abstract

A hybrid receptor molecule composed of the extracellular ligand-binding domain of the human insulin receptor and the transmembrane and cytoplasmic (protein-tyrosine kinase) domains of the chicken sarcoma virus UR2 transforming protein p68gag-ros has been constructed and expressed in Chinese hamster ovary (CHO) cells. The hybrid is processed normally into alpha and hybrid beta subunits, is expressed on the cell surface at high levels, and binds insulin with near-wild-type affinity. Furthermore, insulin stimulates the phosphorylation on tyrosine residues of the hybrid beta subunit in vivo and the phosphorylation of an exogenous substrate [poly(Glu,Tyr)] in vitro. Thus the hybrid is capable of heterologous transmembrane signaling. However, the hybrid mediates neither the insulin-activated uptake of 2-deoxyglucose nor the incorporation of [3H]thymidine into DNA, suggesting that the physiological response(s) mediated by ligand-activated protein-tyrosine kinases may utilize distinct intracellular mechanisms for postreceptor signaling.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299376      PMCID: PMC298801          DOI: 10.1073/pnas.84.15.5101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Linking functional domains of the human insulin receptor with the bacterial aspartate receptor.

Authors:  L Ellis; D O Morgan; D E Koshland; E Clauser; G R Moe; G Bollag; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Mapping surface structures of the human insulin receptor with monoclonal antibodies: localization of main immunogenic regions to the receptor kinase domain.

Authors:  D O Morgan; R A Roth
Journal:  Biochemistry       Date:  1986-03-25       Impact factor: 3.162

3.  Changes in protein phosphorylation in Rous sarcoma virus-transformed chicken embryo cells.

Authors:  J A Cooper; T Hunter
Journal:  Mol Cell Biol       Date:  1981-02       Impact factor: 4.272

4.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

5.  Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue specific and developmentally regulated expression.

Authors:  W S Neckameyer; M Shibuya; M T Hsu; L H Wang
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

6.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

7.  Nucleotide sequence of avian sarcoma virus UR2 and comparison of its transforming gene with other members of the tyrosine protein kinase oncogene family.

Authors:  W S Neckameyer; L H Wang
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin.

Authors:  D O Morgan; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase.

Authors:  D O Morgan; L Ho; L J Korn; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

View more
  10 in total

Review 1.  Role of kinases in insulin stimulation of glucose transport.

Authors:  A Klip; A G Douen
Journal:  J Membr Biol       Date:  1989-10       Impact factor: 1.843

2.  Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor.

Authors:  J A Escobedo; P J Barr; L T Williams
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

3.  Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.

Authors:  V Lhoták; T Pawson
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

4.  Activation of transforming potential of the human insulin receptor gene.

Authors:  L H Wang; B Lin; S M Jong; D Dixon; L Ellis; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.

Authors:  M F Roussel; J R Downing; R A Ashmun; C W Rettenmier; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras.

Authors:  B Poon; D Dixon; L Ellis; R A Roth; W J Rutter; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

7.  Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies.

Authors:  T G Boulton; M H Cobb
Journal:  Cell Regul       Date:  1991-05

8.  Efficient expression in insect cells of a soluble, active human insulin receptor protein-tyrosine kinase domain by use of a baculovirus vector.

Authors:  L Ellis; A Levitan; M H Cobb; P Ramos
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors.

Authors:  H Riedel; T J Dull; A M Honegger; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

10.  Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases.

Authors:  R Brambilla; A Schnapp; F Casagranda; J P Labrador; A D Bergemann; J G Flanagan; E B Pasquale; R Klein
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.